Genentech’s Ocrelizumab First Investigational Medicine to Show Efficacy in People with Primary Progressive Multiple Sclerosis in Large Phase III Study.
Click here to read
Monday, September 28, 2015
Subscribe to:
Post Comments (Atom)
Leading a contented life from a seated position
This is so exciting! It bodes well for so many ms-ers. And gives hope for us SPMS people that something will arrive for us. I know it won't be "on the shelf" any time too soon, but I hope when it does, that it works well for you.
ReplyDelete